Frontiers Current Pharmacological Strategies for Duchenne

Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications

Stem Cell–Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy

EMA starts review of Italfarmaco's Duchenne drug

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management - The Lancet Neurology

Frontiers Care for Patients With Neuromuscular Disorders in the COVID-19 Pandemic Era

Frontiers A Decade of Progress in Gene Targeted Therapeutic Strategies in Duchenne Muscular Dystrophy: A Systematic Review

Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

PDF] New Perspectives in the Management of Duchenne Muscular Dystrophy

Full article: Clinical development on the frontier: gene therapy for duchenne muscular dystrophy

PDF) Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy